Comprehensive Management of Aging in HIV 2025

Eugènia Negredo earned her medical degree and PhD from the Autonomous University of Barcelona (UAB), and completed her residency in Internal Medicine at Sant Pau Hospital.

Since 1999, she has led the HIV Section at Germans Trias i Pujol Hospital (HGTiP) and coordinates a research group focused on HIV-related complications and associated chronic inflammation, with a special emphasis on aging.

She contributes to national and international clinical guidelines on comorbidities and aging (GESIDA, PNS, EACS), and since 2014 has been a professor and coordinator of the Medical degree at UVIC-UCC.

Since 2016, she has co-directed the international workshop “Comprehensive Management of Aging and HIV”, held annually in Barcelona and Buenos Aires.

Dr. Clotet received his MD (1976) and his PhD (1981), with a thesis on autoimmune diseases, from the Autonomous University of Barcelona (UAB). That same year, his internship as an Internal Medicine specialist at the Vall d’Hebron University Hospital in Barcelona coincided with the first AIDS case reported in Spain. This case was the catalyst for a career dedicated to this serious disease, first as head of the HIV Unit of the Germans Trias i Pujol University Hospital in Badalona (1987-2015) and then as founder and president of the Fight against AIDS Foundation (1992), which is now named as Fight Infections Foundation.

Dr. Clotet soon saw the need to go a step beyond patient care to conduct research aimed at eradicating AIDS. In 1995, with the support of “la Caixa” and the Department of Health of the Generalitat of Catalonia, he founded the IrsiCaixa AIDS Research Institute, which he still heads.  In addition, Dr. Clotet is also the clinical director of Infectious Diseases at the Metropolitana Nord area of the Catalan Institute of Health, scientific advisor to two IrsiCaixa spin-offs: Aelix Therapeutics SL and AlbaJuna Therapeutics SL and director of the Chair of AIDS and Related Diseases at the Universitat de Vic (UVic).

He has published more than 1000 papers in high impact international journals and his contributions to research have been recognized with the Josep Trueta medal to Sanitary Merit and the ‘Premi Nacional de Recerca’, among other awards.

Pedro Cahn has been Scientific Director of Fundación Huésped since 1989 and former President of the International AIDS Society (IAS) for the period 2006-2008. Former Head and current Consultant of the Infectology Division of the Juan A. Fernández Hospital in Buenos Aires, Argentina. He is also Full Professor of the Department of Medicine, Infectology Orientation, of the Faculty of Medicine, University of Buenos Aires. Dr. Cahn has been involved in international HIV/AIDS conferences and working groups since 1989, including the 1st Conference on Pathogenesis and Treatment of IAS in Argentina and the XVII International AIDS Conference in Mexico, which he chaired. Likewise, on repeated occasions, he has acted as an advisor to the Pan American Health Organization (PAHO), the World Health Organization (WHO) and UNAIDS. He is an Illustrious Citizen of the City of Buenos Aires and received the honorable mention “Senator Domingo F. Sarmiento” by the Senate of the Nation (2014).

Dr Marta Boffito, MD, PhD, FRCP, is a Consultant physician at Chelsea and Westminster Hospital, and Reader at Imperial College, London, London UK. She is the Clinical Research Lead of the Clinical Research Facility and HIV Service Lead at Chelsea and Westminster Hospital, where she runs numerous research projects and clinical trials, she consults on complex pharmacological issues, sees patients with HIV (she founded the first HIV over-50-years clinic in London, UK), and teaches HIV medicine and pharmacology at Imperial College London and in various National and International settings. She trained in Italy, the USA, and the UK and has a special interest in antiretroviral drug pharmacology: from prevention to treatment. In these areas she contributes to the educational, scientific, and guideline-formulation activities of national bodies including the British HIV Association. She has published over 150 peer-reviewed articles, editorials, and reviews. She has been involved in capacity building programmes for resource-limited settings (e.g. Uganda) and is an applicant on numerous successful collaborative grants.

Professor Patrick (Paddy) Mallon is Professor of Microbial Diseases in the UCD School of Medicine and a Consultant in Infectious Diseases in St Vincent’s University Hospital in Dublin. He graduated in Medicine from Queen’s University Belfast, Northern Ireland and undertook subsequent clinical training in infectious disease medicine in Sydney, Australia where he completed a PhD in long-term toxicities in HIV. Professor Mallon returned to Ireland in 2007 and has led the development of an active research programme in Infectious Diseases. In 2008 he established the HIV Molecular Research Group, which focuses on translational research into toxicities of antiretroviral therapy, strategies to increase population HIV testing and studies aimed at better understanding immune responses to antiretroviral treatment. Professor Mallon is a past-president of the Infectious Diseases Society of Ireland, a regional representative for the European AIDS Clinical Society and the incoming Chair of the co-morbidities Guidelines Panel of the European AIDS Clinical Society. Professor Mallon is also the Director of the Wellcome-Health Research Board Irish Clinical Academic Training Programme.

Pedro Cahn has been Scientific Director of Fundación Huésped since 1989 and former President of the International AIDS Society (IAS) for the period 2006-2008. Former Head and current Consultant of the Infectology Division of the Juan A. Fernández Hospital in Buenos Aires, Argentina. He is also Full Professor of the Department of Medicine, Infectology Orientation, of the Faculty of Medicine, University of Buenos Aires. Dr. Cahn has been involved in international HIV/AIDS conferences and working groups since 1989, including the 1st Conference on Pathogenesis and Treatment of IAS in Argentina and the XVII International AIDS Conference in Mexico, which he chaired. Likewise, on repeated occasions, he has acted as an advisor to the Pan American Health Organization (PAHO), the World Health Organization (WHO) and UNAIDS. He is an Illustrious Citizen of the City of Buenos Aires and received the honorable mention “Senator Domingo F. Sarmiento” by the Senate of the Nation (2014).

Eugènia Negredo earned her medical degree and PhD from the Autonomous University of Barcelona (UAB), and completed her residency in Internal Medicine at Sant Pau Hospital.

Since 1999, she has led the HIV Section at Germans Trias i Pujol Hospital (HGTiP) and coordinates a research group focused on HIV-related complications and associated chronic inflammation, with a special emphasis on aging.

She contributes to national and international clinical guidelines on comorbidities and aging (GESIDA, PNS, EACS), and since 2014 has been a professor and coordinator of the Medical degree at UVIC-UCC.

Since 2016, she has co-directed the international workshop “Comprehensive Management of Aging and HIV”, held annually in Barcelona and Buenos Aires.

Matteo Cesari is a medical doctor specialized in geriatrics, currently working as a Scientist in Geriatrics and Gerontology at the World Health Organization (WHO) in Geneva.

He is a Professor of Geriatrics at the University of Milan (currently on leave), where he also directed the Geriatric Fellowship Program. Prior to joining WHO, he held academic and research positions at the Catholic University of the Sacred Heart in Rome, Wake Forest University (USA), the University of Florida-Institute on Aging, and the University of Toulouse (France).

His research focuses on geriatric syndromes, particularly frailty, and the prevention of functional decline in older adults. He has led and participated in projects funded by major national and international institutions, including the European Commission, the US National Institute on Aging, and various European research foundations.

Dr. Cesari has authored over 650 peer-reviewed publications and has served as Editor-in-Chief or Associate Editor for several scientific journals. He has also coordinated task forces and working groups for leading scientific societies in geriatrics.

Dr. Sereti is the Chief of the HIV Pathogenesis Section in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases (NIAID). She received her Medical Degree at the National University of Athens in Greece and did her Internal Medicine residency and Chief residency at Northwestern University in Chicago. She completed an MHS from Duke University and her Infectious Diseases fellowship at NIAID and stayed at NIAID as clinical investigator receiving tenure in 2015. Her group focuses on studies of HIV-associated inflammation and Idiopathic CD4 lymphopenia along with some work on COVID pathogenesis, in both the clinic and the laboratory. She is a physician scientist who has conducted multiple clinical trials and has published more than 200 peer reviewed papers. Dr Sereti is currently an ELAM fellow and is one of the upcoming Associate Editors of the Journal of Infectious Diseases on her personal time. She is also a member of the Executive committee of the NIH Oxford-Cambridge Scholars program. She is passionate about translational research with excellence in patient care, mentorship, and promotion of women in biomedical sciences.

Professor Patrick (Paddy) Mallon is Professor of Microbial Diseases in the UCD School of Medicine and a Consultant in Infectious Diseases in St Vincent’s University Hospital in Dublin. He graduated in Medicine from Queen’s University Belfast, Northern Ireland and undertook subsequent clinical training in infectious disease medicine in Sydney, Australia where he completed a PhD in long-term toxicities in HIV. Professor Mallon returned to Ireland in 2007 and has led the development of an active research programme in Infectious Diseases. In 2008 he established the HIV Molecular Research Group, which focuses on translational research into toxicities of antiretroviral therapy, strategies to increase population HIV testing and studies aimed at better understanding immune responses to antiretroviral treatment. Professor Mallon is a past-president of the Infectious Diseases Society of Ireland, a regional representative for the European AIDS Clinical Society and the incoming Chair of the co-morbidities Guidelines Panel of the European AIDS Clinical Society. Professor Mallon is also the Director of the Wellcome-Health Research Board Irish Clinical Academic Training Programme.

José Moltó is clinical physician in the HIV Clinic of the Hospital Universitari Germans Trias i Pujol in Badalona, Spain. He obtained is MD from the University of Alicante in 1996, and completed his internal medicine training in the Hospital General Universitario de Elche (Alicante). Since his very early medicine studies, Dr. Moltó was interested in infectious diseases, particularly in HIV infection. He joined the HIV Clinic of the Hospital Universitari Germans Trias i Pujol in 2002, and he obtained his PhD degree from the Universitat Autònoma de Barcelona in 2008. He is committed with HIV research with special interest in clinical pharmacology of antiretroviral treatment, including population pharmacokinetics and drug-drug interactions.

Esteban Martinez studied at the Faculty of Medicine in Valladolid, Spain, from 1980 to 1986. He specialized in Internal Medicine at the Hospital de la Santa Creu i Sant Pau in Barcelona in 1992, and, in 1996, he received his PhD from the Autonomous University of Barcelona with studies on neurosurgical infections.

In 1994, Esteban Martinez started working at the Infectious Diseases Unit of the Hospital Clínic de Barcelona and, since 2001, he has been teaching infectious diseases at the University of Barcelona as Associate Professor of Medicine. He is a member of the Scientific Council of the International Workshop on Adverse Drug Reactions and Co-morbidities in HIV, has co-authored the Guidelines for the Prevention and Management of Non-Infectious Co-Morbidities in HIV (European AIDS Clinical Society), is a member of the European AIDS Clinical Society (EACS) and was elected Regional Representative (Southern Europe) of the EACS in 2012, and has been a founding member of the International Symposium on Psychiatry and HIV. He is a member of the Editorial Board of HIV Medicine, The Scientific World Journal and The Open AIDS Journal.

Dr Marta Boffito, MD, PhD, FRCP, is a Consultant physician at Chelsea and Westminster Hospital, and Reader at Imperial College, London, London UK. She is the Clinical Research Lead of the Clinical Research Facility and HIV Service Lead at Chelsea and Westminster Hospital, where she runs numerous research projects and clinical trials, she consults on complex pharmacological issues, sees patients with HIV (she founded the first HIV over-50-years clinic in London, UK), and teaches HIV medicine and pharmacology at Imperial College London and in various National and International settings. She trained in Italy, the USA, and the UK and has a special interest in antiretroviral drug pharmacology: from prevention to treatment. In these areas she contributes to the educational, scientific, and guideline-formulation activities of national bodies including the British HIV Association. She has published over 150 peer-reviewed articles, editorials, and reviews. She has been involved in capacity building programmes for resource-limited settings (e.g. Uganda) and is an applicant on numerous successful collaborative grants.